Citation: P. Aitola et al., COMPARISON OF N2O AND CO2 PNEUMOPERITONEUMS DURING LAPAROSCOPIC CHOLECYSTECTOMY WITH SPECIAL REFERENCE TO POSTOPERATIVE PAIN, Surgical laparoscopy & endoscopy, 8(2), 1998, pp. 140-144
Authors:
KAHONEN M
YLITALO R
KOOBI T
TURJANMAA V
YLITALO P
Citation: M. Kahonen et al., INFLUENCE OF CAPTOPRIL, PROPRANOLOL, AND VERAPAMIL ON ARTERIAL PULSE-WAVE VELOCITY AND OTHER CARDIOVASCULAR PARAMETERS IN HEALTHY-VOLUNTEERS, International journal of clinical pharmacology and therapeutics, 36(9), 1998, pp. 483-489
Authors:
YLITALO R
KALLIOVALKAMA J
WU XM
KANKAANRANTA H
SALENIUS JP
SISTO T
LAHTEENMAKI T
YLITALO P
PORSTI I
Citation: R. Ylitalo et al., ACCUMULATION OF BISPHOSPHONATES IN HUMAN ARTERY AND THEIR EFFECTS ON HUMAN AND RAT ARTERIAL FUNCTION IN-VITRO, Pharmacology & toxicology, 83(3), 1998, pp. 125-131
Citation: M. Haaga et al., SYSTEMIC AND OCULAR ABSORPTION AND ANTAGONIST ACTIVITY OF TOPICALLY APPLIED CYCLOPENTOLATE IN MAN, Pharmacology & toxicology, 82(1), 1998, pp. 19-22
Authors:
SAHA HHT
ALAHOUHALA IO
LIUKKOSIPI SH
YLITALO P
PASTERNACK AI
Citation: Hht. Saha et al., PHARMACOKINETICS OF CLODRONATE IN PERITONEAL-DIALYSIS PATIENTS, Peritoneal dialysis international, 18(2), 1998, pp. 204-209
Authors:
KAUTIAINEN S
LUURILA S
YLITALO P
YLITALO R
Citation: S. Kautiainen et al., TRANSFORMATION OF BISPHOSPHONATES INTO INSOLUBLE MATERIAL IN HUMAN BLOOD IN-VITRO, Methods and findings in experimental and clinical pharmacology, 20(4), 1998, pp. 289-295
Authors:
KOSONEN O
KANKAANRANTA H
LAHDE M
VUORINEN P
YLITALO P
MOILANEN E
Citation: O. Kosonen et al., NITRIC OXIDE-RELEASING OXATRIAZOLE DERIVATIVES INHIBIT HUMAN LYMPHOCYTE-PROLIFERATION BY A CYCLIC GMP-INDEPENDENT MECHANISM, The Journal of pharmacology and experimental therapeutics, 286(1), 1998, pp. 215-220
Authors:
KERTTULA T
KAUKINEN S
SEPPALA E
RIUTTA A
MUCHA I
YLITALO P
ALANKO J
Citation: T. Kerttula et al., THEOPHYLLINE INFUSION MODULATES PROSTAGLANDIN AND LEUKOTRIENE PRODUCTION IN MAN, Prostaglandins, leukotrienes and essential fatty acids, 57(6), 1997, pp. 555-560
Authors:
KYLMALA T
CASTRENKORTEKANGAS P
SEPPANEN J
YLITALO P
TAMMELA TLJ
Citation: T. Kylmala et al., EFFECT OF CONCOMITANT ADMINISTRATION OF CLODRONATE AND ESTRAMUSTINE PHOSPHATE ON THEIR BIOAVAILABILITY IN PATIENTS WITH METASTASIZED PROSTATE-CANCER, Pharmacology & toxicology, 79(3), 1996, pp. 157-160
Citation: R. Ylitalo et al., ACCUMULATION OF BISPHOSPHONATES IN THE AORTA AND SOME OTHER TISSUES OF HEALTHY AND ATHEROSCLEROTIC RABBITS, The Journal of laboratory and clinical medicine, 127(2), 1996, pp. 200-206
Authors:
YLITALO R
OKSALA O
YLAHERTTUALA S
YLITALO P
Citation: R. Ylitalo et al., EFFECTS OF CLODRONATE (DICHLOROMETHYLENE BISPHOSPHONATE) ON THE DEVELOPMENT OF EXPERIMENTAL ATHEROSCLEROSIS IN RABBITS, The Journal of laboratory and clinical medicine, 123(5), 1994, pp. 769-776
Authors:
KALISTEKORHONEN E
YLITALO P
HANNINEN O
RAUSHEL FM
Citation: E. Kalistekorhonen et al., PHOSPHOTRIESTERASE DECREASES PARAOXON TOXICITY IN MICE, Toxicology and applied pharmacology, 121(2), 1993, pp. 275-278